Optimizing Clinical Outcomes in Blood Cancers

Activity Overview

This activity will provide learners with the latest developments in translational medicine for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.

CE Credit Expired

Target Audience

This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Provide learners with the latest developments in translational medicine for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.

Activity Faculty

Headshot Placeholder Image

Cheryl L. Willman, MD (Chair)

The Maurice & Marguerite Liberman Distinguished Endowed Chair, Cancer Research
UNM Distinguished Professor, Pathology
UNM School of Medicine
Director & CEO
University of New Mexico Comprehensive Cancer Center
Albuquerque, NM

Headshot Placeholder Image

Philippe Armand, MD, PhD

Harold and Virginia Lash/David Lash Chair, Lymphoma Research
Chief, Lymphoma Division
Dana-Farber Cancer Institute
Boston, MA

Headshot Placeholder Image

Catherine M. Bollard, MD, FRACP, FRCPA

Bosworth Chair, Cancer Biology
Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine
Director, Center for Cancer and Immunology Research
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Children’s National Health System
The George Washington University School of Medicine and Health Sciences
Washington, DC

Headshot Placeholder Image

Benjamin L. Ebert, MD, PhD

George P. Canellos, MD and Jean S. Canellos Professor, Medicine
Harvard Medical School
Chair, Department of Medical Oncology
Dana-Farber Cancer Institute,
Boston, MA
Investigator, Howard Hughes Medical Institute

Headshot Placeholder Image

Stephen P. Hunger, MD

Chief, Division of Oncology
Director, Center for Childhood Cancer Research
Jeffrey E. Perelman Distinguished Chair, Department of Pediatrics
Children’s Hospital of Philadelphia
Professor, Department of Pediatrics
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA